Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04385082 · ClinicalTrials.gov registry record · Phase 1

Cannabis Effects as a Function of Sex

A Phase 1 study of Pain and Abuse, Drug, sponsored by University of California, Los Angeles.

Recruiting
Registry status
Phase 1
Development phase
160
Enrollment target
1
Study location

NCT04385082: Recruiting Phase 1 study of Pain and Abuse, Drug, sponsored by University of California, Los Angeles.

NCT04385082 is a Phase 1 study of Pain and Abuse, Drug that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 160 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04385082, a Phase 1 study of Pain and Abuse, Drug, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
Phase 1
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to assess the impact of cannabis on the analgesic and abuse-related effects between men and women

Conditions Studied

Interventions

  • DRUG Active Cannabis
  • DRUG Placebo Cannabis

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2021-07-08
Est. Completion 2027-07-01
Phase Phase 1

What the Registry Record Tells You About NCT04385082

The ClinicalTrials.gov registry entry for NCT04385082 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (47% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Active Cannabis is the first listed.

NCT04385082 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04385082 about?

NCT04385082 is a clinical study titled "Cannabis Effects as a Function of Sex". The purpose of this research is to assess the impact of cannabis on the analgesic and abuse-related effects between men and women

What is the current status of trial NCT04385082?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 160 participants. The study started on 2021-07-08. Estimated completion is 2027-07-01.

What conditions does trial NCT04385082 study?

This clinical trial studies the following conditions: Pain, Abuse, Drug.

What interventions are being tested in trial NCT04385082?

The interventions under investigation include: Active Cannabis (DRUG), Placebo Cannabis (DRUG).

Who is sponsoring clinical trial NCT04385082?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04385082 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.